|
|
|
Volumn 3, Issue 3, 2004, Pages 270-272
|
|
Etanercept for the treatment of psoriasis: combination therapy with other modalities.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
CYCLOSPORIN;
ETRETIN;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
KERATOLYTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ARTICLE;
CASE REPORT;
DOSE RESPONSE;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
PSORIASIS;
PSORIATIC ARTHRITIS;
ACITRETIN;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, PSORIATIC;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
KERATOLYTIC AGENTS;
MALE;
MIDDLE AGED;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECOMBINANT FUSION PROTEINS;
|
|
EID: 3242789475
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (35)
|
|
References (0)
|
